The change, announced by UIC Vice Chancellor for Health Affairs Robert Barish, MD, on March 20, is pending approval by the University of Illinois board of trustees. Dr. Rosenblatt would assume the interim CEO role on May 16, while also remaining executive dean for the University of Illinois College of Medicine.
Dr. Barish announced the interim CEO days after announcing that Michael Zenn is set to step down as CEO in May and move into the new role of senior advisor for enterprise strategic initiatives within the university’s office of the vice chancellor for health affairs.
Dr. Rosenblatt is executive dean for the University of Illinois College of Medicine; professor of ophthalmology, Illinois Lions/Charles I. Young Chair in Ocular Research; director of the Corneal Regenerative Medicine Laboratory; and associate vice chancellor for physician affairs.
University of Illinois Hospital and Clinics is part of the university’s UI Health enterprise. The health system includes a 455-bed hospital and more than 20 outpatient and specialty clinics.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
